ASX Tech Stocks: Bluechiip secures FDA approval and European CE IVD certification for its cryovial line
Link copied to
The company was up 12.5% today, off the back of news it’s own branded cryovials have been registered with the United States FDA (USA) and have received European CE IVD certification.
BCT has now globaly launched its Bluechiip-Enabled sample management solutions product line, including Sample Storage consumables, Readers, and StreamTM Sample Management Software – and plans to market and sell the Bluechiip-Enabled product line directly into North America and Australia/New Zealand and through distribution partners across European and Asia Pacific markets.
“The product launch places Bluechiip in a position to directly market a full range of Bluechiip branded products to end customers,” managing director Andrew McLellan said.
“We are now talking directly to end customers in biobanking, research, clinical trials, and pharmaceutical companies across the life sciences space.
“Importantly, we can now deliver customized readers, software and sample storage consumables.”
IDZ rose by another 13.9% today as it holds it AGM which included an address chairman Stephen Baxter, who detailed the strong financial position and three areas of focus for growth in FY22 including:
The company is also changing its name to xReality Group Ltd (ASX:XRG) and is focused on expanding its Operator Tactical Solutions business unit, which which builds training and simulation products for global defence and law enforcement agencies using Virtual Reality and Augmented Reality technologies.
“Operator was created to solve the problem of integrating training with technology, increasing soldier’s performance and complementing existing training systems,” Baxter said.
“Operator, a wholly owned subsidiary of ISA Group, has been established to capture Defence and related projects within the company.”
The company also flagged its acquisition of VR production studio and content developers Red Cartel in August, included a wholly owned military training prototype which Baxter said is currently being developed into a minimum viable product to be trialled by local and international defence forces later this year.
The cloud-based SaaS logistics platform was up 8.82% in early morning trade, reporting that October saw 184% year on year growth – with the company confident of continued year on year growth in FY22 despite a Covid-impacted September quarter.
YOJ said the maturation of logistics hubs, strong enterprise relationships, on-going hub go lives and expansions have been additional drivers to this high growth phase.
Plus, multiple countries remain on track for hubs to go live by the end of the calendar year including an imminent Europe go-live, which Yojee says further bolsters its momentum and position.
The company’s Yojee Labs and IoT Product focused on intelligent warehouse to assist organisations reach cost and competitive excellence have gained further traction, with the company moving from proof of concept programs into commercial discussions.
“Our embedded growth rollout strategy is being realised with the exponential increase in rates of new go- lives expected by the end of this calendar year and a reduction in time from contract agreement signature with our customers to first revenue from implemented hubs,” managing director Ed Clarke said.
“This is a validation of our strategy and shows the true growth potential of the business.”
Down 5.3% today was Structural Monitoring Systems, which received an arbitration award in relation to a dispute with Tulip Bay Pty Ltd.
In its 2021 Annual Report the company disclosed that a claim royalties amounting to $561,865 including interest was a contingent liability.
The arbitrator has now ruled in favour of Tulip Bay, and due to obligations under the contracts associated with the sale of the CVM sensor technology to SMS, SMS is required to pay Tulip Bay royalties for the years claimed.
Essentially, SMS must pay Tulip Bay the sum of $481,190.34 and further amounts for interest at the rate of 3% per annum:
Down 11.8% today was real-time software company Vection, after receiving firm commitments from predominantly technology focused domestic and international institutional investors for a $12 million placement at $0.20 per share.
Vection says it has “significantly expanded” its M&A war-chest to accelerate its aggressive global acquisition strategy targeting the XR and metaverse enterprise technology sector, anticipating the fierce competition of global technology corporations looking for XR and metaverse exposure, to position the company as a global emerging leader.
“As we anticipate increased M&A interest in the XR and metaverse space, we believe that building size is a critical steppingstone for the global success of Vection Technologies and its stakeholders,” managing director Gianmarco Biagi said.
“This strategic funding round will enable the company to aggressively target M&A transactions globally, aligned with our strong history of well-executed acquisitions with a keen focus on our shareholders interest.”